摘要
[目的]通过动物皮内刺激及致敏试验,对镁合金AZ91D(AZ0)、Mg-Mn-Ce(RE0)及其在三种不同阶跃式阳极氧化表面改性条件下所得新型镁合金(AZ1、AZ2、AZ3、RE1、RE2、RE3)的体内生物相容性进行初步的评价。[方法]按照GB/T16886.10-1997《医疗器械生物学评价》刺激与致敏试验方法进行。采用与生理盐水、高纯镁及医用钛合金Ti-6A1-7Nb对照的研究方法,将镁合金浸提液注入豚鼠皮肤内观察皮内反应:采取皮内注射和涂皮相结合的诱导法观察豚鼠致敏反应。[结果]RE2由于成膜效果较差,无法制备浸提液,剔除出试验组。皮内刺激试验:生理盐水组、Ti-6Al-7Nb、AZ1、AZ3炎性反应I级,评分0分;其余试样皮内刺激反应稍重,有少许充血水肿(Ⅱ级),评分1分。致敏试验:甲醛组炎症反应重(Ⅳ级),肉眼观局部皮肤坏死结痂,致敏4级;生理盐水组无明显炎症反应(Ⅰ级),致敏0级;Ti-6Al-7Nb、AZ1、AZ3炎症反应Ⅱ级,红斑及水肿轻微(Ⅰ级);余试验组炎症反应Ⅲ级,致敏2级。[结论]由以上结果可以初步认为,新型镁合金AZ1、AZ3在皮内刺激及致敏试验中表现较好,具备良好的生物相容性,有望成为新一代的骨科植入材料。
[ Objective] To evaluate the biocompatibility in vivo of Mg alloy AZ91 D (AZ0), Mg- Mn -Ce (RE0 ) and their step anodizational materials ( AZ1, AZ2 , AZ3 , RE1 , RE2 , RE3 ) by the experiments of intradermal stimulus and sensitivity response. [ Methods] According toGB/T 16886. 10 -1997 Biological Evaluation of Medical Apparatus and Instrument, com- pared with normal sodium, pure magnesium and medical Ti -6A1 -7Nb, the leaching liquor were injected into cutis to evaluate stimulus response, to evaluate sensitivity response by injection and illinition. [ Results ] RE2 could not prepare leaching liq- uor, it's kicked out. Intradermal stimulus response: normal sodium, Ti-6A1 -7Nb, AZ1, AZ3 groups inflammation respon- ded as degree I, scored 0. The others inflammation responded as degree II , scored Ⅰ. Sensitivity response: formaldehyde group inflammation responded as degree IV, erythema and edema were degree IV. Normal sodium group inflammation responded as degree Ⅰ, erythema and edema were degree 0. Ti -6A1 -7Nb, AZ1 , AZ3 groups inflammation responded as degree Ⅱ , erythema and edema were degree 1. The others inflammation responses were degree m, erythema and edema were degree Ⅱ. [ Conclusion] The new kinds of magnesium alloy AZ1, AZ3 possesses good preliminary biocompatibility in vivo, so it is very possible to be a new type of bone surgery implant material.
出处
《中国矫形外科杂志》
CAS
CSCD
北大核心
2009年第13期1013-1016,共4页
Orthopedic Journal of China
基金
国家自然科学基金资助项目(编号:30700179)